eXoZymes, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $60.3M
- Price
- $6.50
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.56%
- Volume
- 1.6K
About
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Quick stats
Shares outstanding9.3M
Computed float2.5M
Float / shares27.2%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0002010788
Websitehttps://exozymes.com
AI Summary
AI-generated1/13
standardbullishoperations update
eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets
eXoZymes reported a 10-fold productivity increase in its manufacturing process for NCT, driven by an 80% reduction in reaction time and a 67% increase in output per liter compared to its pilot run.
Internal assessments indicate estimated manufacturing costs have fallen more than 100x since the first process iteration, exceeding the company's original commercial-scale economic targets.
The company is now preparing the optimized process for technology transfer to commercial partners to advance toward scalable production.
Red flags
- Economic improvements based on internal estimates, not third-party validation
- Company is pre-revenue; commercial viability not yet proven